Meiji Holdings Co., Ltd. (2269)

6,670.0 +20.0 (+0.30%)
Close JPY Disclaimer

Meiji Holdings Co., Ltd. Company Profile

Food Products
Equity Type
Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter and margarine, cream, ice cream, ready meals, chocolates, gummy products, chewing gums, sports nutrition products, infant formula, liquid diet, beauty supplements, OTC medicines, feed stuffs, corn sweeteners, and sugar, as well as transportation and distribution services. The company also offers drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and animal vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, disinfectants, oral administration, insecticides, anthelmintic, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents. In addition, it provides insecticides, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.
Contact Information
Tokyo,104-0031 Japan
81 3 3273 4001
Top Executives
Michiko Kuboyama 65 2021 Independent Outside Director
Mariko Matsumura 0 2018 Independent Outside Director
Masaya Kawata 69 2021 Independent Outside Director
Katsunari Matsuda 0 2018 COO of Food Segment, Member of the Board & Executive Officer
Koichiro Shiozaki 0 2011 CFO, Member of the Board, Sr. Managing Executive Officer of Corp. Admin. & Risk Management Dept.
Kazuo Kawamura 69 2012 CEO, President, Repres. Director, President- Corp. Develop., Group HR Strategy & Co-Creation Center
Daikichiro Kobayashi 68 2014 COO of Pharmaceutical Segment, Member of the Board & Executive Officer
Jun Furuta 65 2014 CSO, Director, Sr. Exec. Officer, Managing Exec. Officer of Corporate Comm. & Sustainability Mgt.
Hajime Watanabe 63 2013 Independent Outside Audit & Supervisory Board Member
Hiroaki Chida 63 2021 Audit & Supervisory Board Member
Peter D. Pedersen 55 2022 Independent Outside Director
Takayoshi Ohno 62 2021 Audit & Supervisory Board Member
Makoto Ando 63 2017 Independent Outside Audit & Supervisory Board Member
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles